Ikarian Capital’s HOOKIPA Pharma HOOK Stock Holding History

Ikarian Capital’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-52,996	Closed	-$66.5K	–	181
2025 Q2	$66.5K	Hold	52,996	–	–	0.01%	127
2025 Q1	$57.2K	Hold	52,996	–	–	0.01%	155
2024 Q4	$107K	Sell	52,996 -80	-0.2%	-$248	0.01%	155
2024 Q3	$228K	Buy	+53,076	New	+$280K	0.03%	135
2024 Q2	–	Sell	-53,078	Closed	-$378K	–	137
2024 Q1	$378K	Hold	53,078	–	–	0.04%	126
2023 Q4	$430K	Hold	53,078	–	–	0.04%	118
2023 Q3	$327K	Sell	53,078 -6,922	-12%	-$50.8K	0.04%	115
2023 Q2	$528K	Buy	+60,000	New	+$666K	0.08%	98

Other funds holding HOOK

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Ikarian Capital's HOOK Position: Q3 2025 in Review

Ikarian Capital sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 52,996 shares — an estimated $66.5K sold.

Ikarian Capital first reported a position in HOOK in Q2 2023 and held it in 8 quarters. The position peaked at $528K in Q2 2023. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.

Ikarian Capital reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
Ikarian Capital sold 52,996 HOOKIPA Pharma shares in Q3 2025, an estimated $66.5K.
Ikarian Capital first reported a position in HOOKIPA Pharma in Q2 2023 and held it in 8 quarters.
Ikarian Capital's HOOKIPA Pharma position peaked at $528K in Q2 2023.
6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.

Based on Ikarian Capital's 13F filing for Q3 2025, filed 14 Nov 2025.